J Gordon Curtis

Ethical challenges around using the military and veterans for psychedelic research abound. Let’s examine the health, ethical, and moral implications of this.

ATAI Life Sciences' failed R-ketamine study in January caused a stock freefall, revealing both the volatility and greed of the corporate psychedelics sector.

Psilocybin-containing mushrooms and other hallucinogenic substances are shaking up the field dominated by failing abstinence-only 12-step programs.

Biden recently announced major rollbacks to the accommodations put in place during the pandemic. Here’s what it means for patients

When researchers compare something to a placebo, they aren't comparing it to the absence of any effect. Here's how our body creates real effects from fake drugs.

Rep. Nancy Mace (R-SC) recently moved to amend tax code 280E, which keeps cannabis businesses from making tax deductions. Is there finally momentum for change?

With a democratically-controlled government, Minnesota is making big moves toward recreational marijuana legalization. Here’s how it’s shaking out.

Days after Oregon published its final rules for psilocybin clinics, Senator Steiner introduced a bill overturning key rights advocates had fought hard for.

As more states legalize the sale of marijuana, banking regulations restrict many from operating. Women- and minority-owned businesses are often hit hardest.